Literature DB >> 30057411

Metabolic disorders: IDO inhibitors could change tack to treat metabolic disorders.

Megan Cully.   

Abstract

Entities:  

Year:  2018        PMID: 30057411     DOI: 10.1038/nrd.2018.124

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health.

Authors:  Ludivine Laurans; Nicolas Venteclef; Yacine Haddad; Mouna Chajadine; Fawaz Alzaid; Sarvenaz Metghalchi; Bruno Sovran; Raphael G P Denis; Julien Dairou; Marina Cardellini; Jose-Maria Moreno-Navarrete; Marjolene Straub; Sarah Jegou; Claire McQuitty; Thomas Viel; Bruno Esposito; Bertrand Tavitian; Jacques Callebert; Serge H Luquet; Massimo Federici; José Manuel Fernandez-Real; Remy Burcelin; Jean-Marie Launay; Alain Tedgui; Ziad Mallat; Harry Sokol; Soraya Taleb
Journal:  Nat Med       Date:  2018-06-25       Impact factor: 53.440

  1 in total
  1 in total

Review 1.  Amino Acids and Their Transporters in T Cell Immunity and Cancer Therapy.

Authors:  Weimin Wang; Weiping Zou
Journal:  Mol Cell       Date:  2020-09-29       Impact factor: 17.970

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.